NuOrtho Surgical Inc. added another former Johnson & Johnson (NYSE:JNJ) alum to its executive suite, naming Ian McRury as its new chief science officer.
McRury’s most recent position was research and development manager for CR Bard Inc. (NYSE:BCR). He also spent nine years as a principal engineer for J&J’s DePuy Mitek division in Raynham, Mass.
NuOrtho, which is headquartered in Fall River, Mass., is developing a device that uses radio frequencies to repair torn or frayed cartilage in the knee. The company has raised $2 million to date in two rounds of financing.
NuOrtho president and CEO Jeffrey Morrill is a former marketing director for DePuy Mitek.
